Advertisement
Laser monotherapy improves health-related quality of life in female patients with radiation-induced breast telangiectasias

Laser Improves QOL for Breast Telangiectasia Due to Radiation

0
Significant improvements seen in emotional and functional Skindex-16 HR-QOL domains, overall score
Obstetrician-gynecologists should be aware of who is eligible for cascade testing

ACOG Advocates Cascade Testing for Hereditary Gene Mutations

0
Ob-gyns should identify eligible patients, offer testing, and assist in decreasing barriers to testing
Pharmaceutical aids are not effective for increasing long-term smoking cessation

Pharmaceutical Aids Not Found to Be Helpful for Smoking Cessation

0
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence
There are noticeable differences in hospice utilization among patients with malignant glioma

Variation Seen in Hospice Use for Malignant Glioma

0
Differences by race, sex, age, level of education, urban versus rural residence identified
Across cancers

Out-of-Pocket Costs Correlate With Receipt of Cancer Care

0
Across cancers, higher costs tied to higher rates of oral prescription abandonment, delayed initiation
About three-quarters of patients in California who receive End of Life Option Act drugs ingest them and die

Three-Quarters Receiving ‘End of Life Option Act’ Drugs Take Them

0
Common reasons for pursuing California's EOLOA are not wanting to suffer, not being able to enjoy life
Atopic dermatitis is associated with an increased risk of developing squamous cell carcinoma

Atopic Dermatitis Associated With Higher Risk of Skin Cancer

0
Individuals with a history of atopic dermatitis have a higher risk of squamous cell carcinoma development
Helping patients understand individualized reasons for opioid tapering and encouraging them to provide input into the process are key for patient-provider communications

Tips Offered for Patient-Provider Opioid Tapering Talks

0
Patients should understand individualized reasons for tapering, know their providers will not abandon them
Rituximab treatment seems effective for systemic lupus erythematosus-associated immune cytopenias

Rituximab Effective for Lupus-Associated Cytopenia

0
Overall initial response rate of 86 percent in 71 patients, with complete response for 60.5 percent
For patients with human papillomavirus+ stage I or II oropharyngeal cancer

Reducing Tx May Harm Safety in Early HPV+ Oropharyngeal Cancer

0
For patients with stage III disease, intensification to triple-modality therapy may improve survival